Human Endogenous Retroviruses and Their Putative Role in the Development of Autoimmune Disorders Such as Multiple Sclerosis
- PMID: 29515547
- PMCID: PMC5826199
- DOI: 10.3389/fmicb.2018.00265
Human Endogenous Retroviruses and Their Putative Role in the Development of Autoimmune Disorders Such as Multiple Sclerosis
Abstract
Human endogenous retroviruses (HERVs) are remnants of retroviral germ line infections of human ancestors and make up ~8% of the human genome. Under physiological conditions, these elements are frequently inactive or non-functional due to deactivating mutations and epigenetic control. However, they can be reactivated under certain pathological conditions and produce viral transcripts and proteins. Several disorders, like multiple sclerosis or amyotrophic lateral sclerosis are associated with increased HERV expression. Although their detailed contribution to individual diseases has yet to be elucidated, an increasing number of studies in vitro and in vivo suggest HERVs as potent modulators of the immune system. They are able to affect the transcription of other immune-related genes, interact with pattern recognition receptors, and influence the positive and negative selection of developing thymocytes. Interestingly, HERV envelope proteins can both stimulate and suppress immune responses based on different mechanisms. In the light of HERV proteins becoming an emerging drug target for autoimmune-related disorders and cancer, we will provide an overview on recent findings of the complex interactions between HERVs and the human immune system with a focus on autoimmunity.
Keywords: HERV; autoimmunity; disease; immune system; superantigen.
Similar articles
-
Contribution of Human Retroviruses to Disease Development-A Focus on the HIV- and HERV-Cancer Relationships and Treatment Strategies.Viruses. 2020 Aug 4;12(8):852. doi: 10.3390/v12080852. Viruses. 2020. PMID: 32759845 Free PMC article. Review.
-
Human Endogenous Retroviruses Are Ancient Acquired Elements Still Shaping Innate Immune Responses.Front Immunol. 2018 Sep 10;9:2039. doi: 10.3389/fimmu.2018.02039. eCollection 2018. Front Immunol. 2018. PMID: 30250470 Free PMC article. Review.
-
Expression of HERV Genes as Possible Biomarker and Target in Neurodegenerative Diseases.Int J Mol Sci. 2019 Jul 29;20(15):3706. doi: 10.3390/ijms20153706. Int J Mol Sci. 2019. PMID: 31362360 Free PMC article. Review.
-
Human endogenous retroviruses and cancer.Cancer Biol Med. 2016 Dec;13(4):483-488. doi: 10.20892/j.issn.2095-3941.2016.0080. Cancer Biol Med. 2016. PMID: 28154780 Free PMC article.
-
HERV Envelope Proteins: Physiological Role and Pathogenic Potential in Cancer and Autoimmunity.Front Microbiol. 2018 Mar 14;9:462. doi: 10.3389/fmicb.2018.00462. eCollection 2018. Front Microbiol. 2018. PMID: 29593697 Free PMC article. Review.
Cited by
-
Exploring HERV-K (HML-2) Influence in Cancer and Prospects for Therapeutic Interventions.Int J Mol Sci. 2023 Sep 27;24(19):14631. doi: 10.3390/ijms241914631. Int J Mol Sci. 2023. PMID: 37834078 Free PMC article. Review.
-
Mycobacterium paratuberculosis: A HERV Turn-On for Autoimmunity, Neurodegeneration, and Cancer?Microorganisms. 2024 Sep 13;12(9):1890. doi: 10.3390/microorganisms12091890. Microorganisms. 2024. PMID: 39338563 Free PMC article. Review.
-
HSV-1 and Endogenous Retroviruses as Risk Factors in Demyelination.Int J Mol Sci. 2021 May 27;22(11):5738. doi: 10.3390/ijms22115738. Int J Mol Sci. 2021. PMID: 34072259 Free PMC article. Review.
-
Expression profile of HERVs and inflammatory mediators detected in nasal mucosa as a predictive biomarker of COVID-19 severity.Front Microbiol. 2023 May 22;14:1155624. doi: 10.3389/fmicb.2023.1155624. eCollection 2023. Front Microbiol. 2023. PMID: 37283924 Free PMC article.
-
Multiple Sclerosis patients carry an increased burden of exceedingly rare genetic variants in the inflammasome regulatory genes.Sci Rep. 2019 Jun 24;9(1):9171. doi: 10.1038/s41598-019-45598-x. Sci Rep. 2019. PMID: 31235738 Free PMC article.
References
-
- Badenhoop K., Donner H., Neumann J., Herwig J., Kurth R., Usadel K. H., et al. (1999). IDDM patients neither show humoral reactivities against endogenous retroviral envelope protein nor do they differ in retroviral mRNA expression from healthy relatives or normal individuals. Diabetes 48, 215–218. 10.2337/diabetes.48.1.215 - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources